• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高用药安全性:特定患者的开处方者反馈计划对澳大利亚普通执业医生进行用药审查率的影响。

Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.

作者信息

Roughead Elizabeth, Pratt Nicole, Peck Robert, Gilbert Andrew

机构信息

Quality Use of Medicines and Pharmacy Research Centre; Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5001, Australia.

出版信息

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):797-803. doi: 10.1002/pds.1393.

DOI:10.1002/pds.1393
PMID:17476702
Abstract

PURPOSE

To determine if patient-specific prescriber feedback for general medical practitioners (GPs), supported by educational material mailed to their patients, would increase home medicines review (HMR) rates.

METHODS

An observational study was conducted using the Repatriation Pharmaceutical Benefits Scheme (RPBS) Pharmacy Claims Database. The intervention group (n = 40 270) included all veterans aged >/=65 years, dispensed >/=5 unique medicines each month over a 4 month period. Comparison group veterans (n = 49,227) were those who did not have >/=5 or more unique medicines dispensed each month, but did have at least one prescription each month and >/=20 prescriptions over 4 months, of which five were unique medicines, Intervention GPs (n = 11,384) were subdivided into 2 groups: GPs with intervention veterans (n = 2097) and GPs with both intervention and comparison group veterans (n = 9287). The comparison group of GPs (n = 3630) were primary prescribers to the comparison veterans only. Rates of HMRs pre and post-intervention and the number of new GPs participating in HMR services were examined.

RESULTS

There was a significant increase in HMR rates in intervention group, from 2.2 per 1000 in the pre-period to 4.6 per 1000 per month in the post-intervention period (Rate Ratio (RR) 2.06, 95% Confidence Interval (CI) (1.90, 2.22), p < 0.0001). HMR rates increased in the intervention group compared with the comparison group (p < 0.0001). HMR rates increased in the intervention group GPs compared with the comparison group (RR 1.79, 95% CI (1.58, 2.02), p < 0.0001).

CONCLUSION

Patient-specific feedback provided to GPs, supported by educational material mailed directly to their patients increased HMR rates for targeted veterans and increased GP participation in the delivery of HMRs.

摘要

目的

确定向全科医生(GP)提供针对患者的处方者反馈,并辅以邮寄给患者的教育材料,是否会提高家庭药物审查(HMR)率。

方法

使用退伍军人药品福利计划(RPBS)药房索赔数据库进行了一项观察性研究。干预组(n = 40270)包括所有年龄≥65岁的退伍军人,在4个月期间每月配发≥5种不同药物。对照组退伍军人(n = 49227)是那些每月未配发≥5种或更多不同药物,但每月至少有一张处方且在4个月内有≥20张处方(其中5种为不同药物)的退伍军人。干预组全科医生(n = 11384)分为两组:有干预组退伍军人的全科医生(n = 2097)和既有干预组又有对照组退伍军人的全科医生(n = 9287)。对照组全科医生(n = 3630)仅为对照组退伍军人的主要开方者。研究了干预前后的HMR率以及参与HMR服务的新全科医生数量。

结果

干预组的HMR率显著增加,从干预前的每1000人2.2例增加到干预后时期的每月每1000人4.6例(率比(RR)2.06,95%置信区间(CI)(1.90,2.22),p < 0.0001)。与对照组相比,干预组的HMR率有所增加(p < 0.0001)。与对照组相比,干预组全科医生的HMR率有所增加(RR 1.79,95% CI(1.58,2.02),p < 0.0001)。

结论

向全科医生提供针对患者的反馈,并辅以直接邮寄给患者的教育材料,提高了目标退伍军人的HMR率,并增加了全科医生参与HMR服务的程度。

相似文献

1
Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.提高用药安全性:特定患者的开处方者反馈计划对澳大利亚普通执业医生进行用药审查率的影响。
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):797-803. doi: 10.1002/pds.1393.
2
Polypharmacy management among Australian veterans: improving prescribing through the Australian Department of Veterans' Affairs' prescriber feedback programme.澳大利亚退伍军人的多重用药管理:通过澳大利亚退伍军人事务部的处方者反馈计划改善处方开具情况。
Intern Med J. 2008 Feb;38(2):95-100. doi: 10.1111/j.1445-5994.2007.01453.x. Epub 2007 Nov 13.
3
Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.学术推广干预对老年人环氧化酶-2抑制剂使用率的影响。
Ann Pharmacother. 2008 Jun;42(6):749-56. doi: 10.1345/aph.1K537. Epub 2008 Apr 22.
4
Relation between physician characteristics and prescribing for elderly people in New Brunswick.新不伦瑞克省医生特征与老年人处方开具之间的关系。
CMAJ. 1994 Mar 15;150(6):917-21.
5
Physical activity promotion in primary care: bridging the gap between research and practice.初级保健中的身体活动促进:弥合研究与实践之间的差距。
Am J Prev Med. 2004 Nov;27(4):297-303. doi: 10.1016/j.amepre.2004.07.012.
6
Paediatric homoeopathy in general practice: where, when and why?全科医疗中的儿科顺势疗法:地点、时间与原因?
Br J Clin Pharmacol. 2005 Jun;59(6):743-9. doi: 10.1111/j.1365-2125.2004.02213.x.
7
A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy.一项集群随机试验,比较学术推广反馈与邮政公告对预防性心血管治疗处方的影响。
Fam Pract. 2007 Oct;24(5):475-80. doi: 10.1093/fampra/cmm044. Epub 2007 Aug 1.
8
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.回顾性药物利用审查对老年人潜在不适当处方的影响。
Am J Geriatr Pharmacother. 2009 Feb;7(1):11-9. doi: 10.1016/j.amjopharm.2009.02.004.
9
[General practitioners' attitudes towards psychotic disorders and their treatment in the primary health care system].[全科医生对原发性卫生保健系统中精神障碍及其治疗的态度]
Turk Psikiyatri Derg. 2003 Summer;14(2):106-15.
10
Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.在全科医疗中提高慢性收缩性心力衰竭药物治疗的指南依从性——一项临床实践指南实施的整群随机对照试验结果
J Eval Clin Pract. 2008 Oct;14(5):823-9. doi: 10.1111/j.1365-2753.2008.01060.x.

引用本文的文献

1
Safer Prescribing and Care for the Elderly (SPACE): a cluster randomised controlled trial in general practice.老年人安全用药与护理(SPACE):一项全科医疗中的整群随机对照试验。
BJGP Open. 2022 Mar 22;6(1). doi: 10.3399/BJGPO.2021.0129. Print 2022 Mar.
2
Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial.提高初级保健中抗高血压药物不良反应的患者自我报告率:一项阶梯式楔形集群随机试验。
BMC Fam Pract. 2021 Aug 7;22(1):165. doi: 10.1186/s12875-021-01478-w.
3
Interventions to improve the appropriate use of polypharmacy for older people.
改善老年人合理使用多种药物的干预措施。
Cochrane Database Syst Rev. 2018 Sep 3;9(9):CD008165. doi: 10.1002/14651858.CD008165.pub4.
4
Medication reviews are useful, but the model needs to be changed: Perspectives of Aboriginal Health Service health professionals on Home Medicines Reviews.药物审查是有用的,但模式需要改变:原住民健康服务机构的健康专业人员对家庭药物审查的看法。
BMC Health Serv Res. 2015 Sep 10;15:366. doi: 10.1186/s12913-015-1029-3.
5
The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.癌症药物在常规临床护理中的使用与影响:澳大利亚老年人群队列的方法与观察
BMJ Open. 2014 May 2;4(5):e004099. doi: 10.1136/bmjopen-2013-004099.
6
Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial.评价初级保健中预防药物不良事件的互动程序:InPAct 群组随机阶梯式楔形试验研究方案。
Implement Sci. 2013 Jun 19;8:69. doi: 10.1186/1748-5908-8-69.
7
A pharmacist-led intervention for increasing the uptake of Home Medicines Review (HMR) among residents of retirement villages (PHARMER): protocol for a cluster randomised controlled trial.药剂师主导的干预措施提高退休村居民接受家庭用药回顾(HMR)的比例(PHARMER):一项群组随机对照试验的方案。
BMC Health Serv Res. 2011 Oct 31;11:292. doi: 10.1186/1472-6963-11-292.
8
Challenges in chronic illness management: a qualitative study of Australian pharmacists' perspectives.慢性病管理中的挑战:对澳大利亚药剂师观点的定性研究
Pharm World Sci. 2010 Oct;32(5):631-6. doi: 10.1007/s11096-010-9414-9. Epub 2010 Jul 14.
9
Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany.在德国农村地区跨学科医疗保健模式中药物相关问题的检测
Pharm World Sci. 2010 Oct;32(5):566-74. doi: 10.1007/s11096-010-9409-6. Epub 2010 Jul 1.
10
Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).比较澳大利亚和新斯科舍省(加拿大)非甾体抗炎药和环氧化酶-2(COX-2)抑制剂的使用情况。
Br J Clin Pharmacol. 2009 Jul;68(1):106-15. doi: 10.1111/j.1365-2125.2009.03410.x.